Figure 3. FDG uptake in oesophageal cancer prior to and following therapy before surgical removal of the tumour. SUV decreases in the responding patient by over 70%, while SUV in the non-responder changes less than 30% [17].
Figure 3. FDG uptake in oesophageal cancer prior to and following therapy before surgical removal of the tumour. SUV decreases in the responding patient by over 70%, while SUV in the non-responder changes less than 30% [17].